TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12394419

Group type: EXPERIMENTAL
Intervention: Alprazolam (0.25, 0.50, 0.75 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Buspirone (5, 10, 15 mg)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 28
Study: 9869282

Group type: EXPERIMENTAL
Intervention: Overdenture supported by two IMZ implants (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Overdenture supported by four IMZ implants (group B)
Number of subjects: 60
Study: 8041168

Group type: COMPARATOR
Intervention: Mechanical valve (Bjork‐Shiley spherical disc)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Bioprosthetic valve (Hancock porcine heterograft)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 66

Group type: COMPARATOR
Intervention: Surgical intervention and antibiotics
Number of subjects: 66

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Preoperative endocarditis
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Multivalvular disease surgery
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Superficial wound infection
Number of subjects: 66
Study: 2924744

Group type: EXPERIMENTAL
Intervention: Carbamazepine (CBZ)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Gamma-vinyl GABA (GVG)
Number of subjects: 17
Study: 162669

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltaren) 25 mg t.i.d.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Indomethacin 25 mg t.i.d.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 30889044

Group type: EXPERIMENTAL
Intervention: Intra-Aortic Balloon Pump (IABP) therapy
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: SelP levels above the 75th percentile at day 3 following AMI
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: SelP levels
Number of subjects: 600
Study: 29538790

Group type: EXPERIMENTAL
Intervention: Life review intervention (Haight Structured Life Review with modified guiding questions and memory prompts)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual nursing home care (control group)
Number of subjects: 74
Study: 27502326

Group type: EXPERIMENTAL
Intervention: Fimasartan/Amlodipine 60 mg/10 mg
Number of subjects: 143

Group type: COMPARATOR
Intervention: Fimasartan 60 mg
Number of subjects: 143
Study: 24939043

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 22874682

Group type: EXPERIMENTAL
Intervention: graft + laparoscopic Nissen fundoplication
Number of subjects: 24

Group type: COMPARATOR
Intervention: laparoscopic Nissen fundoplication alone
Number of subjects: 24
Study: 20471543

Group type: EXPERIMENTAL
Intervention: Oral morphine
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Oral midazolam
Number of subjects: 63
Study: 18331278

Group type: EXPERIMENTAL
Intervention: Hypocrisy condition (delivered a speech on dangers of smoking)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypocrisy condition (wrote a passage about healthy lifestyle)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 15634953

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PV)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Control vaccine (CV)
Number of subjects: 383
Study: 11913801

Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.1 microg kg(‐1) min(‐1))
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 10352852

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intent-to-treat analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethical standards and independent data monitoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian statistical methods
Number of subjects: 0
Study: 7490601

Group type: EXPERIMENTAL
Intervention: Dietary fish oil supplementation for 3 months
Number of subjects: 395

Group type: COMPARATOR
Intervention: Heterogeneous dietary control oils
Number of subjects: 395
Study: 2149044

Group type: EXPERIMENTAL
Intervention: teicoplanin plus ciprofloxacin
Number of subjects: 80

Group type: COMPARATOR
Intervention: gentamicin plus piperacillin
Number of subjects: 80
Study: 463800

Group type: EXPERIMENTAL
Intervention: Mixed protein intake
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Concurrent energy provision
Number of subjects: 4
Study: 31813633

Group type: EXPERIMENTAL
Intervention: Obeticholic acid 10 mg
Number of subjects: 931

Group type: EXPERIMENTAL
Intervention: Obeticholic acid 25 mg
Number of subjects: 931

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 931
Study: 29288478

Group type: EXPERIMENTAL
Intervention: Cryobiopsy (CB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Forceps biopsy
Number of subjects: 0
Study: 26357703

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD) 0.1 mL topically applied to soft tissues surrounding implants
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (no treatment applied)
Number of subjects: 5
Study: 23351812

Group type: EXPERIMENTAL
Intervention: Oral prednisolone for 6 weeks
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Mycobacterium w injection for 3 months
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Safety of immunomodulatory treatment
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Placebo for oral prednisolone
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Placebo for Mycobacterium w injection
Number of subjects: 1400
Study: 21076814

Group type: EXPERIMENTAL
Intervention: flexion
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: flexion and compression
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: compression
Number of subjects: 147

Group type: COMPARATOR
Intervention: control
Number of subjects: 147
Study: 19247497

Group type: EXPERIMENTAL
Intervention: Combined epidural analgesia and neuraxial anesthesia (epidural group)
Number of subjects: 494

Group type: COMPARATOR
Intervention: Intravenous opioid analgesia and general anesthesia (IV group)
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Follow-up
Number of subjects: 494

Group type: EXPERIMENTAL
Intervention: Recruitment rate
Number of subjects: 494
Study: 17298428

Group type: EXPERIMENTAL
Intervention: Methylprednisolone aceponate 0.1% ointment once daily
Number of subjects: 265

Group type: COMPARATOR
Intervention: Tacrolimus 0.03% ointment twice daily
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Methylprednisolone aceponate 0.1% ointment
Number of subjects: 265

Group type: COMPARATOR
Intervention: Tacrolimus 0.03% ointment
Number of subjects: 265
Study: 12649058

Group type: EXPERIMENTAL
Intervention: Move It Groove It intervention
Number of subjects: 1045

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1045
Study: 10918715

Group type: EXPERIMENTAL
Intervention: Esophageal transit for liquid bolus
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Gastric emptying time (T50)
Number of subjects: 58
Study: 8809580

Group type: EXPERIMENTAL
Intervention: Portocaval shunt
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sugiura procedure
Number of subjects: 15
Study: 1430968

Group type: EXPERIMENTAL
Intervention: norfloxacin
Number of subjects: 122

Group type: COMPARATOR
Intervention: nalidixic acid
Number of subjects: 122
Study: 2996332

Group type: EXPERIMENTAL
Intervention: Enalapril (10 to 20 mg bid)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (25 to 50 mg bid)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Combination therapy (Enalapril + Hydrochlorothiazide)
Number of subjects: 39
Study: 31540535

Group type: EXPERIMENTAL
Intervention: Participatory nutrition education sessions (group EDU)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Participatory nutrition education sessions with mobile food application (group EDU + APP)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 79
Study: 30017276

Group type: EXPERIMENTAL
Intervention: Tumor group (n=10)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (n=40)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 26365930

Group type: EXPERIMENTAL
Intervention: AquaLase
Number of subjects: 50

Group type: COMPARATOR
Intervention: NeoSoniX
Number of subjects: 50
Study: 24176534

Group type: EXPERIMENTAL
Intervention: Supportive-expressive therapy (SET)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Antidepressant medication (MED)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 156
Study: 22749221

Group type: EXPERIMENTAL
Intervention: PICSI
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sperm Slow
Number of subjects: 100
Study: 19835829

Group type: EXPERIMENTAL
Intervention: 3.75 microg H5N1 with 50% MF59
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: All doses of MF59 with various antigen levels
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 753

Group type: EXPERIMENTAL
Intervention: Second dose of vaccine
Number of subjects: 753
Study: 17889386

Group type: EXPERIMENTAL
Intervention: Late course accelerated fractionated (LCAF) radiotherapy
Number of subjects: 178

Group type: COMPARATOR
Intervention: Conventional fractionation radiotherapy
Number of subjects: 178
Study: 15892593

Group type: EXPERIMENTAL
Intervention: Dexrazoxane
Number of subjects: 0
Study: 12456612

Group type: EXPERIMENTAL
Intervention: FSH + LH
Number of subjects: 2

Group type: COMPARATOR
Intervention: FSH alone
Number of subjects: 2
Study: 9821828

Group type: EXPERIMENTAL
Intervention: Echinacea angustifolia
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Echinacea purpurea
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Echinacea treatments
Number of subjects: 302
Study: 7522003

Group type: EXPERIMENTAL
Intervention: Argon green laser
Number of subjects: 141

Group type: COMPARATOR
Intervention: Krypton red laser
Number of subjects: 141
Study: 2475392

Group type: EXPERIMENTAL
Intervention: Endoscopic endoprosthesis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Operative bypass surgery
Number of subjects: 50
Study: 331937

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Chlorpromazine
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Glyceryl guaiacolate
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Diphenhydramine
Number of subjects: 54

Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 54
Study: 30420171

Group type: EXPERIMENTAL
Intervention: Weight-loss intervention with guidance for 0.5 to 1 kg/week weight-loss via energy restriction and aerobic exercise.
Number of subjects: 32
Study: 30827784

Group type: EXPERIMENTAL
Intervention: Frozen single blastocyst transfer
Number of subjects: 1650

Group type: COMPARATOR
Intervention: Fresh single blastocyst transfer
Number of subjects: 1650
Study: 30110685

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 26585525

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol (FP/SAL)
Number of subjects: 2141
Study: 24636673

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 20332

Group type: COMPARATOR
Intervention: Aspirin plus extended-release dipyridamole
Number of subjects: 20332

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 20332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20332
Study: 22248661

Group type: EXPERIMENTAL
Intervention: FPSA
Number of subjects: 145

Group type: COMPARATOR
Intervention: SMT
Number of subjects: 145
Study: 19408640

Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional tonsillectomy with bipolar diathermy coagulation
Number of subjects: 72
Study: 17642235

Group type: EXPERIMENTAL
Intervention: Tocilizumab (humanized anti-human IL-6 receptor antibody)
Number of subjects: 0
Study: 15080023

Group type: EXPERIMENTAL
Intervention: Barnidipine hydrochloride at a titrated dose of 10-15 mg once daily for 8 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Barnidipine hydrochloride
Number of subjects: 40
Study: 11262334

Group type: EXPERIMENTAL
Intervention: Educative intervention for primary care physicians about dyslipidaemia management.
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Dietetic therapy
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: HMG-CoA-reductase inhibitors
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Fibric-acid derivates
Number of subjects: 705

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Experimental group (after intervention)
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Diet management only
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: Fibric-acid derivates management
Number of subjects: 705

Group type: EXPERIMENTAL
Intervention: HMG-CoA-reductase inhibitors management
Number of subjects: 705
Study: 9741499

Group type: EXPERIMENTAL
Intervention: Triage angiography
Number of subjects: 201

Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 201
Study: 8042733

Group type: EXPERIMENTAL
Intervention: Intra-articular morphine 2 mg in 40 ml of normal saline
Number of subjects: 33

Group type: COMPARATOR
Intervention: Intramuscular morphine 2 mg in 1 ml of normal saline
Number of subjects: 33
Study: 3172799

Group type: EXPERIMENTAL
Intervention: 1 unit of fresh whole blood
Number of subjects: 27

Group type: COMPARATOR
Intervention: 10 units of platelet concentrates
Number of subjects: 27

Group type: COMPARATOR
Intervention: 8 units of platelet concentrates
Number of subjects: 27
Study: 1429339

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) consisting of topical polymyxin E, tobramycin, and amphotericin B administered throughout the unit stay together with parenteral ceftazidime for the first three days.
Number of subjects: 91

Group type: COMPARATOR
Intervention: Historical control group treated conventionally.
Number of subjects: 91

Group type: COMPARATOR
Intervention: Contemporaneous control group treated conventionally.
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Contemporaneous control group
Number of subjects: 91
Study: 644633

Group type: EXPERIMENTAL
Intervention: Nurses providing family planning services
Number of subjects: 0

Group type: COMPARATOR
Intervention: Physicians providing family planning services
Number of subjects: 0
Study: 31552815

Group type: EXPERIMENTAL
Intervention: H. pylori IgG antibody sero-prevalence among Arabs
Number of subjects: 1651

Group type: COMPARATOR
Intervention: H. pylori IgG antibody sero-prevalence among Jews
Number of subjects: 1651

Group type: EXPERIMENTAL
Intervention: CagA IgG antibody sero-positivity among H. pylori positives in Arabs
Number of subjects: 1651

Group type: COMPARATOR
Intervention: CagA IgG antibody sero-positivity among H. pylori positives in Jews
Number of subjects: 1651
Study: 27718262

Group type: EXPERIMENTAL
Intervention: Tulobuterol patch (TP)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Salmeterol inhaler (SA)
Number of subjects: 33
Study: 24948413

Group type: EXPERIMENTAL
Intervention: Perhexiline
Number of subjects: 286

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 286
Study: 24943857

Group type: EXPERIMENTAL
Intervention: 50 mg (2 mL) dexketoprofen
Number of subjects: 50

Group type: COMPARATOR
Intervention: 2 mL normal saline (control)
Number of subjects: 50
Study: 22070862

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (non-responders)
Number of subjects: 40
Study: 20014650

Group type: EXPERIMENTAL
Intervention: Start unstable condition (high instability along the first half of the trajectory decreasing as the target was approached)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: End unstable condition (instability increasing along the first half of the trajectory and remaining high as the target was approached)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Null field condition (neutral stability everywhere)
Number of subjects: 0

Group type: COMPARATOR
Intervention: End unstable condition
Number of subjects: 0
Study: 17317393

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 30
Study: 15451743

Group type: EXPERIMENTAL
Intervention: Intensive-lifestyle intervention
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Reimbursable-lifestyle intervention
Number of subjects: 152

Group type: COMPARATOR
Intervention: Usual-care
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: All groups (including usual-care)
Number of subjects: 152
Study: 11391126

Group type: EXPERIMENTAL
Intervention: 100 mg entacapone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 200 mg entacapone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 400 mg entacapone
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 9679843

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (50 or 100 microg twice daily)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (100 microg twice daily)
Number of subjects: 325

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study: 7982173

Group type: EXPERIMENTAL
Intervention: OK-432 (intratumoral injection)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Control (no injection)
Number of subjects: 395
Study: 2512765

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 mcg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 mcg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Misoprostol 800 mcg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 30231121

Group type: EXPERIMENTAL
Intervention: Resistance training (24-week program)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (standard pharmacological treatment)
Number of subjects: 35
Study: 26089103

Group type: EXPERIMENTAL
Intervention: EUS-guided rendezvous (EUS-RV)
Number of subjects: 20
Study: 24809448

Group type: EXPERIMENTAL
Intervention: Levodopa/Carbidopa treatment for patients with low DβH activity genotypes (CT/TT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo treatment for patients with low DβH activity genotypes (CT/TT)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Levodopa/Carbidopa treatment for patients with normal DβH activity genotype (CC)
Number of subjects: 71
Study: 22322214

Group type: EXPERIMENTAL
Intervention: Early tracheostomy (ET)
Number of subjects: 100
Study: 19663753

Group type: EXPERIMENTAL
Intervention: Web site intervention based on social cognitive theory (SCT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 91
Study: 19020325

Group type: EXPERIMENTAL
Intervention: Early antiretroviral therapy
Number of subjects: 377

Group type: COMPARATOR
Intervention: Deferred antiretroviral therapy
Number of subjects: 377
Study: 15821274

Group type: EXPERIMENTAL
Intervention: Pramlintide mixed with short-acting insulin
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Pramlintide mixed with long-acting insulin
Number of subjects: 51

Group type: COMPARATOR
Intervention: Separate injections of pramlintide and insulin
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Pramlintide and insulin mixtures
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 51
Study: 12052589

Group type: EXPERIMENTAL
Intervention: Loop electrosurgical excision procedure during luteal phase
Number of subjects: 60

Group type: COMPARATOR
Intervention: Loop electrosurgical excision procedure during follicular phase
Number of subjects: 60
Study: 10391163

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 10 ml through a subcutaneous catheter
Number of subjects: 104

Group type: COMPARATOR
Intervention: Dipyrone 500 mg orally
Number of subjects: 104
Study: 8871418

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy plus family management (CBT + FAM)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Waiting list (Control)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Overall treatment effectiveness
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: CBT vs CBT + FAM
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Age and gender interaction
Number of subjects: 79
Study: 1637600

Group type: EXPERIMENTAL
Intervention: 0.25 MAC isoflurane
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.5 MAC isoflurane
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.75 MAC isoflurane
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1 MAC isoflurane
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0 MAC isoflurane (control)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isoflurane administration
Number of subjects: 10
Study: 6207648

Group type: EXPERIMENTAL
Intervention: Ethambutol (20 mg/kg bodyweight/day) with streptomycin and isoniazid (SHE)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Streptomycin, isoniazid and thioacetazone (SHT)
Number of subjects: 134
Study: 11863299

Group type: EXPERIMENTAL
Intervention: Formulation 1 (150 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Formulation 2 (150 mg)
Number of subjects: 6
Study: 29913374

Group type: EXPERIMENTAL
Intervention: Trastuzumab (12 months)
Number of subjects: 1631
Study: 27977585

Group type: EXPERIMENTAL
Intervention: Combined physical‐, cognitive‐, and mindfulness training (PCMT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Reference group (control)
Number of subjects: 112
Study: 25456363

Group type: EXPERIMENTAL
Intervention: Unfav-dose-dense group
Number of subjects: 263

Group type: COMPARATOR
Intervention: Unfav-BEP group
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Fav-BEP group
Number of subjects: 263